Fletcher C, Peto R (1977) The natural history of chronic
airflow limitation. Br Med J 1:1645–1648
Garey KW, Neuhauser MM, Robbins RA, Danziger LH,
Rubinstein I (2004) Markers of inflammation in
exhaled breath condensate of young healthy smokers.
Chest 125:22–26
GOLD (2015) Global initiative for obstructive lung dis-
ease. Global strategy for the diagnosis, management
and prevention of chronic obstructive pulmonary dis-
ease. 2015 update. http://www.goldcopd.org.
Accessed 18 Jan 2016
Go ́rska K, Maskey-Warze ̨chowska M, Krenke R (2010)
Airway inflammation in chronic obstructive pulmo-
nary disease. Curr Opin Pulm Med 16:89–96
Hoonhorst SJM, Timens W, Koenderman L, Lo Tam Loi
AT, Lammers JW, Boezen HM, van Oosterhout AJ,
Postma DS, Ten Hacken NH (2014) Increased activa-
tion of blood neutrophils after cigarette smoking in
young individuals susceptible to COPD. Respir Res
15:121–130
Horvath I, Hunt J, Barnes PJ et al (2005) Exhaled breath
condensate: methodological recommendations and
unresolved questions. Eur Respir J 26:523–548
Koczulla AR, Noeske S, Herr C, Jӧrres RA, Rӧmmelt H,
Vogelmeier C, Bals R (2010) Acute and chronic
effects of smoking on inflammation markers in
exhaled breath condensate in current smokers. Respi-
ration 79:61–67
Konstantinidi EM, Lappas AS, Tzortzi AS, Behrakis PK
(2015) Exhaled breath condensate: technical and diag-
nostic aspects. ScientificWorldJournal 2015:435160.
doi:10.1155/2015/435160
Kostikas K, Minas M, Nikolaou E et al (2013) Second-
hand smoke exposure induces acutely airway acidifi-
cation and oxidative stress. Respir Med 107:172–179
Kotz D, van de Kant K, J€obsis Q, van Schayck CP (2007)
Effects of tobacco exposure on lung health and pul-
monary biomarkers in young, healthy smokers aged
12–25 years: a systematic review. Expert Rev Respir
Med 1:403–418
Lommatzsch M, Bratke K, Knappe T, Bier A,
Dreschler K, Kuepper M, Stoll P, Julius P, Virchow
JC (2010) Acute effects of tobacco smoke on human
airway dendritic cells in vivo. Eur Respir J
35:1130–1136
Miller MR, Hankinson J, Brusasco V et al (2005)
Standardisation of spirometry. Eur Respir J
26:319–338
Papaioannou AI, Koutsokera A, Tanou K, Kiropoulos TS,
Tsilioni I, Oikonomidi S, Liadaki K, Pournaras S,
Gourgoulianis KI, Kostikas K (2010) The acute effect
of smoking in healthy and asthmatic smokers. Eur J
Clin Investig 40:103–109
Pellegrino R, Viegi G, Brusasco V et al (2005) Interpreta-
tive strategies for lung function tests. Eur Respir J
26:948–968
Rovina N, Koutsoukou A, Koulouris NG (2013) Inflam-
mation and immune response in COPD: where do we
stand? Mediators Inflamm 2013:413735. doi:10.1155/
2013/413735
Ryder MI, Saghizadeh M, Ding Y, Nguyen N, Soskolne A
(2002) Effects of tobacco smoke on the secretion of
interleukin 1β, tumor necrosis factor α and
transforming growth factorβfrom peripheral blood
mononuclear cells. Oral Microbiol Immunol
17:331–336
Tanni SE, Pelegrino NRG, Angeleli AYO, Correa C,
Godoy I (2010) Smoking status and tumor necrosis
factor-alpha mediated systemic inflammation in
COPD patients. J Inflamm 7:29–35
van der Toorn M, Slebos DJ, de Bruin HG, Gras R,
Rezayat D, Jorge L, Sandra K, Oosterhout AJ (2013)
Critical role of aldehydes in cigarette smoke-induced
acute airway inflammation. Respir Res 14:45–56
van der Vaart H, Postma DS, Timens W, ten Hacken NH
(2004) Acute effects of cigarette smoke on inflamma-
tion and oxidative stress: a review. Thorax
59:713–721
van der Vaart H, Postma DS, Timens W, Hylkema MN,
Willemse BW, Boezen HM, Vonk JM, de Reus DM,
Kauffman HF, ten Hacken NH (2005) Acute effects of
cigarette smoking on inflammation in healthy inter-
mittent smokers. Respir Res 6:22–32
WCRF (2016) World Cancer Research Fund Interna-
tional. Lung cancer statistics.http://www.wcrf.org/
int/cancer-facts-figures. Accessed 18 Jan 2016
WHO (2016) Prevalence of tobacco use. Global health
observatory data. http://www.who.int/gho/tobacco/
use. Accessed 18 Jan 2016.80 M. Maskey-Warze ̨ chowska et al.